Aligos Therapeutics Inc. (ALGS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

34.67

1.55%

After-hours Dec 13, 2024, 07:59 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	15.53M	13.91M	4.36M	-	-	-
Cost of Revenue	3.07M	3.67M	104.15M	3.33M	2.30M	1.29M
Gross Profit	12.46M	10.23M	-99.79M	-3.33M	-2.30M	-1.29M
Operating Income	-88.13M	-97.58M	-128.32M	-97.83M	-54.04M	-13.66M
Interest Income	1.24M	1.64M	132.00K	1.26M	1.56M	163.00K
Pretax Income	-86.88M	-95.94M	-128.19M	-108.38M	-52.18M	-13.93M
Net Income	-87.68M	-96.05M	-128.33M	-108.54M	-52.26M	-13.93M
Selling & General & Admin	30.62M	26.41M	28.53M	17.94M	10.01M	3.21M
Research & Development	73.04M	85.08M	104.15M	79.89M	44.04M	10.46M
Other Expenses	-	-	-	-10.55M	302.00K	-435.00K
Operating Expenses	103.66M	111.49M	132.68M	97.83M	54.04M	13.66M
Interest Expense	-	1.64M	132.00K	10.55M	-	-
Selling & Marketing Expenses	-	-	-	-	-	-
Cost & Expenses	102.96M	111.49M	132.68M	97.83M	54.04M	13.66M
Income Tax	795.00K	106.00K	143.00K	161.00K	85.00K	-272.00K
Shares Outstanding (Basic)	24.87M	42.70M	39.86M	34.18M	21.93M	21.17M
Shares Outstanding (Diluted)	24.87M	42.70M	39.86M	34.18M	21.93M	21.17M
EPS (Basic)	-3.52	-2.25	-3.22	-3.18	-2.38	-0.66
EPS (Diluted)	-3.52	-2.25	-3.22	-3.18	-2.38	-0.66
EBITDA	-85.06M	-93.91M	-124.54M	-105.06M	-49.88M	-12.37M
Depreciation & Amortization	3.07M	3.67M	3.78M	3.33M	2.30M	1.29M